The endothelium: influencing vascular smooth muscle in many ways

Triggle, Chris R.; Samuel, Samson Mathews; Ravishankar, Shalini; Marei, Isra; Arunachalam, Gnanapragasam; Ding, Hong
June 2012
Canadian Journal of Physiology & Pharmacology;Jun2012, Vol. 90 Issue 6, p713
Academic Journal
The endothelium, although only a single layer of cells lining the vascular and lymphatic systems, contributes in multiple ways to vascular homeostasis. Subsequent to the 1980 report by Robert Furchgott and John Zawadzki, there has been a phenomenal increase in our knowledge concerning the signalling molecules and pathways that regulate endothelial - vascular smooth muscle communication. It is now recognised that the endothelium is not only an important source of nitric oxide (NO), but also numerous other signalling molecules, including the putative endothelium-derived hyperpolarizing factor (EDHF), prostacyclin (PGI2), and hydrogen peroxide (H2O2), which have both vasodilator and vasoconstrictor properties. In addition, the endothelium, either via transferred chemical mediators, such as NO and PGI2, and (or) low-resistance electrical coupling through myoendothelial gap junctions, modulates flow-mediated vasodilatation as well as influencing mitogenic activity, platelet aggregation, and neutrophil adhesion. Disruption of endothelial function is an early indicator of the development of vascular disease, and thus an important area for further research and identification of potentially new therapeutic targets. This review focuses on the signalling pathways that regulate endothelial - vascular smooth muscle communication and the mechanisms that initiate endothelial dysfunction, particularly with respect to diabetic vascular disease.


Related Articles

  • Regulation of Endothelial Nitric Oxide Synthase in Pathophysiological Conditions. Isenović, Esma R.; Soskić, Sanja; Düngen, Hans-Dirk; Dobutović, Branislava; Elvis, Tahirović; Simone, Inkrot; Marche, Pierre // Cardiovascular & Haematological Disorders - Drug Targets;Sep2011, Vol. 11 Issue 2, p109 

    The nitric oxide (NO) cascade and endothelial NO synthase (eNOS) are best known for their role in endothelium-mediated relaxation of vascular smooth muscle (VSM). NO generated by eNOS has been established as a key regulatory signaling molecule in the vasculature. The activities of eNOS are...

  • Direct Endothelial Nitric Oxide Synthase Activation Provides Atheroprotection in Diabetes-Accelerated Atherosclerosis. Sharma, Arpeeta; Sellers, Stephanie; Stefanovic, Nada; Leung, Cleo; Sih Min Tan; Huet, Olivier; Granville, David J.; Cooper, Mark E.; de Haan, Judy B.; Bernatchez, Pascal; Tan, Sih Min // Diabetes;Nov2015, Vol. 64 Issue 11, p3937 

    Patients with diabetes have an increased risk of developing atherosclerosis. Endothelial dysfunction, characterized by the lowered bioavailability of endothelial NO synthase (eNOS)-derived NO, is a critical inducer of atherosclerosis. However, the protective aspect of eNOS in diabetes-associated...

  • RAGE: A Single Receptor for Several Ligands and Different Cellular Responses: The Case of Certain S100 Proteins. Donato, Rosario // Current Molecular Medicine;Dec2007, Vol. 7 Issue 8, p711 

    The S100 protein family comprises at least 25 members which, with the exception of S100G, act as Ca2+-sensor proteins that participate in Ca2+ signal transduction by interacting with target proteins thereby modifying their activities. S100 proteins are expressed in vertebrates exclusively,...

  • Modulatory Role of Nitric Oxide/cGMP System in Endothelin-1-Induced Signaling Responses in Vascular Smooth Muscle Cells. Kapakos, Georgia; Bouallegue, Ali; Daou, Grace Bou; Srivastava, Ashok K. // Current Cardiology Reviews;Nov2010, Vol. 6 Issue 4, p247 

    No abstract available.

  • The role of cGMP/cGKI signalling and Trpc channels in regulation of vascular tone. Loga, Florian; Domes, Katrin; Freichel, Marc; Flockerzi, Veit; Dietrich, Alexander; Birnbaumer, Lutz; Hofmann, Franz; Wegener, Jörg W. // Cardiovascular Research;Nov2013, Vol. 100 Issue 2, p280 

    Aims Signalling via cGMP-dependent protein kinase I (cGKI) is the major pathway in vascular smooth muscle (SM), by which endothelial NO regulates vascular tone. Recent evidence suggests that canonical transient receptor potential (Trpc) channels are targets of cGKI in SM and mediate the relaxant...

  • Mitochondrial Mechanisms in Cerebral Vascular Control: Shared Signaling Pathways with Preconditioning. Busija, David W.; Katakam, Prasad V. // Journal of Vascular Research;2014, Vol. 51 Issue 3, p175 

    Mitochondrial-initiated events protect the neurovascular unit against lethal stress via a process called preconditioning, which independently promotes changes in cerebrovascular tone through shared signaling pathways. Activation of adenosine triphosphate (ATP)-dependent potassium channels on the...

  • Twenty-five years since the discovery of endothelium-derived relaxing factor (EDRF): does a dysfunctional endothelium contribute to the development of type 2 diabetes? Triggle, Chris R.; Howarth, Andrew; Zhong Jian Cheng; Hong Ding // Canadian Journal of Physiology & Pharmacology;Aug2005, Vol. 83 Issue 8/9, p681 

    Twenty-five years ago, the discovery of endothelium-derived relaxing factor opened a door that revealed a new and exciting role for the endothelium in the regulation of blood flow and led to the discovery that nitric oxide (NO) multi-tasked as a novel cell-signalling molecule. During the next 25...

  • Circulating and Vascular Bioactive Factors During Hypertension in Pregnancy. Tanbe, Alain F.; Khalil, Raouf A. // Current Bioactive Compounds;Mar2010, Vol. 6 Issue 1, p60 

    Normal pregnancy is associated with significant vascular remodeling in the uterine and systemic circulation in order to meet the metabolic demands of the mother and developing fetus. The pregnancy-associated vascular changes are largely due to alterations in the amount/activity of vascular...

  • Endothelium-independent conversion of angiotensin I by vascular smooth muscle cells. Coulet, Florence; Gonzalez, Walter; Boixel, Christophe; Meilhac, Olivier; Pueyo, Maria E.; Michel, Jean-Baptiste // Cell & Tissue Research;Feb2001, Vol. 303 Issue 2, p227 

    The conversion of angiotensin I (AT-I) to angiotensin II (AT-II) by angiotensin I-converting enzyme (ACE) is a key step in the action of angiotensins. ACE is constitutively expressed in endothelial cells, but can also be detected at low levels in smooth muscle cells (SMC). Furthermore, in rats...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics